Search

everythinglearnresearchcommunity

for

Search:↓

The new classification system for skin disorders emphasizes the importance of understanding a patient's awareness of their condition for better treatment.

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Seborrheic dermatitis affects quality of life and sleep, linked to stress and nervous system changes.

Hair loss in Chinese college students leads to various psychological issues, so treatment should address both hair loss and mental health.

Women with PCOS are more likely to experience depression and have a negative body image compared to women without PCOS.

The HAIR-Q is a reliable tool for assessing patient satisfaction with hair loss treatments.

Alopecia Areata patients experience higher social appearance anxiety due to visible hair loss.

Mindfulness intervention greatly improves quality of life and reduces distress in women with breast cancer.

Patients with hair loss are much more likely to have body dysmorphic disorder than general dermatology patients.

Depression and hair loss may influence each other.

Finasteride increases risk of depression, possibly suicidal thoughts, and sexual dysfunction.

Measuring hair glucocorticoids for stress is moderately feasible, especially in females and those with moderate intellectual disabilities.

Chronic finasteride use in male rats doesn't strongly cause depression or anxiety due to adaptive stress hormone changes.

The COVID-19 pandemic increased symptoms in people with skin picking and hair pulling disorders.

Alopecia areata impacts mental well-being more due to perceptions and stigma than disease severity.

No proven link between isotretinoin and depression.

Women with female pattern hair loss tend to have lower self-esteem and body image concerns, but higher self-esteem is linked to more self-compassion.

Pseudofolliculitis barbae is linked to higher rates of anxiety and depression.

Skin diseases can cause psychological issues, and better integration of dermatology and psychiatry is needed to improve patient care.

The Spanish version of the Hair Specific Skindex-29 scale is a reliable and valid way to measure the impact of hair loss on women's quality of life.

The survey helps identify menstrual irregularities and excess male hormones, aiming to detect conditions like Polycystic Ovary Syndrome.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

Finasteride may cause depression and suicidal thoughts, especially in young men.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.